Abrysvo New-FDA Approves Pfizer mRNA Bioweapon for RSV, Common Cold

First published at 18:39 UTC on June 2nd, 2023.
subscribers

On May 31, 2023 the agency formerly known as the FDA, now working with the DOD, announced full licensing approval for Pfizer's Abrysvo, another mRNA poison for a respiratory syncytial virus (RSV) with the symptoms & duration of the common c…

MORE
CategoryHealth & Medical
SensitivityNormal - Content that is suitable for ages 16 and over
DISCUSS THIS VIDEO